ArticleMicrobial genomics2026
Conservation, origin, and remodeling of the phenyl acetate degradation pathway.
Article in Microbial genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aromatic hydrocarbons are widespread environmental compounds whose microbial degradation is essential for detoxification, yet the genomic distribution and evolutionary stability of many catabolic pathways remain poorly understood. The phenylacetic acid (PAA) hybrid pathway integrates aerobic and anaerobic features and represents a central route for aromatic compound degradation; however, its prevalence, evolutionary conservation and regulatory organization across prokaryotes have not been comprehensively reassessed.Here, we investigated the global distribution, structural conservation and evolutionary dynamics of the PAA pathway across prokaryotic genomes. We performed a large-scale comparative genomic analysis of 6,536 bacterial and archaeal genomes, leveraging functionally annotated genomes to enable consistent identification of pathway components, integrating protein architecture profiling, genomic context organization, phylogenetics, motif and structural analyses of phenylacetate-CoA ligase (PAL) and cophylogenetic inference. Using stringent criteria, we identified 853 high-confidence PAL predictions across 825 genomes (≈12%), revealing substantial previously unrecognized PAA metabolic potential. Structural analyses confirmed the conservation of key catalytic features, supporting functional annotation of newly identified PALs. Genomic context analyses revealed extensive pathway remodelling across lineages, yet a conserved core of local regulatory elements mediated by PaaX, PaaR and PaaY was maintained. Notably, PaaX and PaaR were, for the first time, predicted to co-occur within the same genomic context organization in several groups. In contrast, archaeal genomes predominantly encode incomplete PAA configurations, suggesting functional divergence and/or pathway fragmentation.Together, these results demonstrate that the PAA pathway is more widespread and evolutionarily dynamic than previously appreciated, combining deep enzymatic conservation with flexible genomic organization. Finally, the conservation of the core epoxidase subunits PaaA and PaaC across PAL-encoding genomes supports their use as robust genomic markers of PAA pathway potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.